Folgen
Akash Das
Akash Das
Assistant Professor of Molecular Genetics
Bestätigte E-Mail-Adresse bei utsouthwestern.edu
Titel
Zitiert von
Zitiert von
Jahr
Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis
A Das, MS Brown, DD Anderson, JL Goldstein, A Radhakrishnan
elife 3, e02882, 2014
3352014
Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection
F Lu, Q Liang, L Abi-Mosleh, A Das, JK De Brabander, JL Goldstein, ...
Elife 4, e12177, 2015
3022015
Use of mutant 125I-perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells
A Das, JL Goldstein, DD Anderson, MS Brown, A Radhakrishnan
Proceedings of the National Academy of Sciences 110 (26), 10580-10585, 2013
1222013
CGI-58 facilitates the mobilization of cytoplasmic triglyceride for lipoprotein secretion in hepatoma cellss⃞
JM Brown, S Chung, A Das, GS Shelness, LL Rudel, L Yu
Journal of lipid research 48 (10), 2295-2305, 2007
712007
Triazoles inhibit cholesterol export from lysosomes by binding to NPC1
MN Trinh, F Lu, X Li, A Das, Q Liang, JK De Brabander, MS Brown, ...
Proceedings of the National Academy of Sciences 114 (1), 89-94, 2017
662017
Identification of putative active site residues of ACAT enzymes
A Das, MA Davis, LL Rudel
Journal of lipid research 49 (8), 1770-1781, 2008
502008
Identification of the interaction site within acyl-CoA: cholesterol acyltransferase 2 for the isoform-specific inhibitor pyripyropene A
A Das, MA Davis, H Tomoda, S Ômura, LL Rudel
Journal of biological chemistry 283 (16), 10453-10460, 2008
412008
Detection of Startle-Type Epileptic Seizures using Machine Learning Technique
P Balakrishnan, S Hemalatha, DNS Keshav
International Journal of Epilepsy 5 (02), 092-098, 2018
42018
ORIC-114, an orally bioavailable, irreversible kinase inhibitor, has superior brain penetration and antitumor activity in subcutaneous and intracranial NSCLC models
JE Long, S Kim, HY Kim, DG Shin, DH Park, R Warne, A Das, G Hegde, ...
Cancer Research 82 (12_Supplement), 3335-3335, 2022
32022
ORIC-114, a brain penetrant, orally bioavailable, irreversible inhibitor selectively targets EGFR and HER2 exon20 insertion mutants and regresses intracranial NSCLC xenograft …
MR Junttila, S Kim, Y Lee, H Kim, J Kang, J Seok, J Yoo, Y Lee, DH Seo, ...
Cancer Research 81 (13_Supplement), 1466-1466, 2021
22021
A comparative analysis of intracellular cholesterol esterifying enzymes in mammals
A Das
Wake Forest University, The Bowman Gray School of Medicine, 2009
12009
Selective degradation of mutant PIK3CA promotes increased mutant specificity in a subset of PI3K ATP-competitive inhibitors
L Nguyen, K Edgar, K Song, S Schmidt, V Schutz, N Ishisoko, E Torres, ...
MOLECULAR CANCER RESEARCH 18 (10), 43-43, 2020
2020
Abstract PR03: Selective degradation of mutant PIK3CA promotes increased mutant specificity in a subset of PI3K ATP-competitive inhibitors
L Nguyen, K Edgar, K Song, S Schmidt, V Schutz, N Ishisoko, E Torres, ...
Molecular Cancer Research 18 (10_Supplement), PR03-PR03, 2020
2020
The following manuscript will be submitted to Journal of Biological Chemistry. Stylistic variations are due to the requirements of the journal. A. Das conceived the project …
A Das
A dissertation submitted to the graduate faculty of 1050, 2009
2009
The following manuscript was published in the Journal of Lipid Research 2008 volume 49 pages 1770-1781 and is reprinted with permission. Stylistic variations are due to the …
A Das
A dissertation submitted to the graduate faculty of 1050, 2009
2009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–15